Hypernatremia is a serious event that can occur during intravenous (IV) treatment with fosfomycin, and it can also be caused by a wrong drug preparation. Considering the clinical significance of hypernatremia, we decided to carry out two studies by using two different data sources with the aim to evaluate cases of IV fosfomycin-induced hypernatremia. A retrospective medical record review was performed from June 2017 to June 2019 using data from two hospitals in Southern Italy.
View Article and Find Full Text PDFBackground: Effective communication strategies in health care help to enhance patient empowerment and improve clinical outcomes.
Objective: Adapt the original Communication Assessment (CAT) instrument for the pharmacist profession (CAT-Pharm) and to test its validity and reliability in two different settings.
Setting: Five hospital pharmacies in Italy and five community pharmacies in Malta.